PATENT CLAIM ANALYSIS

Application Number: 15911816
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "272100"]

Abstract:
Immunogenic compositions and vaccines against Plasmodial infection comprising an Rh polypeptide or a fragment or variant thereof are disclosed. Also disclosed are Rh5 polypeptides or fragments or variants thereof capable of binding CD147 and conferring protection against infection and/or disease caused by multiple Plasmodial strains or Plasmodial species, inhibitors of the interaction between Rh5 and CD147 and methods for producing polypeptides in a mammalian expression system.

Claim (Index 22):
A vaccine comprising a polypeptides or polynucleotides as disclosed in any of  claims 14  to  19 , or combination thereof.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 90.0
- Lexical Diversity: 1.40816
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14786509', '15507173', '11622845', '09500376', '15129230']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7019946450920749
- 35 USC 102 Novelty (BERT): 0.523599995204755
- Combined Prediction Score: 0.684155180103343
- Mean Citation Score: 299.076008
- Max Citation Score: 307.97726
- Similarity Product: 211.92349713499192

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test